Arrowgrass Capital Partners (US)’s Medtronic MDT Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,281	Closed	-$1.98M	–	251
2019 Q2	$1.98M	Sell	20,281 -15,758	-44%	-$1.44M	0.05%	266
2019 Q1	$3.28M	Buy	+36,039	New	+$3.23M	0.1%	211
2018 Q1	–	Sell	-45,284	Closed	-$3.66M	–	344
2017 Q4	$3.66M	Sell	45,284 -23,658	-34%	-$1.89M	0.04%	337
2017 Q3	$5.36M	Buy	+68,942	New	+$5.72M	0.04%	360
2017 Q2	–	Sell	-17,250	Closed	-$1.45M	–	617
2017 Q1	$1.39M	Buy	17,250 +15,803	+1,092%	+$1.23M	0.01%	460
2016 Q4	$103K	Buy	+1,447	New	+$114K	﹤0.01%	519
2016 Q3	–	Sell	-12,600	Closed	-$1.09M	–	471
2016 Q2	$1.09M	Buy	+12,600	New	+$1.02M	0.01%	336
2015 Q4	–	Sell	-3,368	Closed	-$225K	–	442
2015 Q3	$225K	Buy	+3,368	New	+$248K	﹤0.01%	422

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s MDT Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Medtronic (MDT) in Q3 2019, closing a stake of 20,281 shares — an estimated $1.98M sold.

Arrowgrass Capital Partners (US) first reported a position in MDT in Q3 2015 and held it in 8 quarters. The position peaked at $5.36M in Q3 2017. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

Arrowgrass Capital Partners (US) reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 20,281 Medtronic shares in Q3 2019, an estimated $1.98M.
Arrowgrass Capital Partners (US) first reported a position in Medtronic in Q3 2015 and held it in 8 quarters.
Arrowgrass Capital Partners (US)'s Medtronic position peaked at $5.36M in Q3 2017.
1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.